
“23andMe Inc., the Google Inc.-backed DNA analysis company co-founded by Anne Wojcicki, was told by U.S. regulators to halt sales of its main product because it’s being sold without ‘marketing clearance or approval.’ The Saliva Collection Kit and Personal Genome Service, or PGS, tells users whether they carry a disease, are at risk of a disease and would respond to a drug. Most of the uses fall into the category of a medical device and require Food and Drug Administration approval, the agency told the Mountain View, California-based company in a Nov. 22 letter made public today.”
Related posts:
Looking for Hashish in Cairo? Talk to the Police
New demolition technique shrinks Tokyo hotel ‘in a clean manner’
Barack Obama is pushing gun control at home, but he’s a killer abroad
Yahoo, Dell Swell Netherlands’ $13 Trillion Tax Haven
'The Fight Over Medical Marijuana’
Bin Laden son-in-law court appearance reignites debate over handling of terrorism cases
U.S. chooses Afghanistan for first "mother of all bombs" drop
Google, once disdainful of lobbying, now a master of Washington influence
U.S. Keeps Nuclear First-Strike Option [2010]
U.S. House approves sweeping $633 billion defense spending bill
Officials: 80 Percent Of Recent NYC High School Graduates Cannot Read
Hostess, maker of Twinkies, to go out of business after nationwide strike
Tallest Skyscraper Yet Going Up In Midland, Texas
Egypt fears run on its banks as it imposes limit on amount people can withdraw
Second NM driver gets cavity searched after stop for failure to signal